{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:24:29Z","timestamp":1761989069378,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13045-017-0440-0","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T08:55:59Z","timestamp":1490259359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Thrombus leukocytes exhibit more endothelial cell-specific angiogenic markers than peripheral blood leukocytes do in acute coronary syndrome patients, suggesting a possibility of trans-differentiation: a comprehensive database mining study"],"prefix":"10.1186","volume":"10","author":[{"given":"Hangfei","family":"Fu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nish","family":"Vadalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric R.","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luqiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudette","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric T.","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-6195","authenticated-orcid":false,"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,23]]},"reference":[{"key":"440_CR1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcm.2008.11.004","volume":"18","author":"J Mestas","year":"2008","unstructured":"Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228\u201332.","journal-title":"Trends Cardiovasc Med"},{"key":"440_CR2","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1152\/physrev.00006.2013","volume":"93","author":"J-S Silvestre","year":"2013","unstructured":"Silvestre J-S, Smadja DM, L\u00e9vy BI. Postischemic revascularization: from cellular and molecular mechanisms to clinical applications. Physiol Rev. 2013;93:1743\u2013802.","journal-title":"Physiol Rev"},{"key":"440_CR3","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2741\/4055","volume":"17","author":"F Du","year":"2012","unstructured":"Du F, Zhou J, Gong R, Huang X, Pansuria M, Virtue A, et al. Endothelial progenitor cells in atherosclerosis. Front Biosci (Landmark Ed). 2012;17:2327\u201349.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"440_CR4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nri3064","volume":"11","author":"GT Motz","year":"2011","unstructured":"Motz GT, Coukos G. The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol. 2011;11:702\u201311.","journal-title":"Nat Rev Immunol"},{"key":"440_CR5","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2015.02.034","volume":"65","author":"M Nahrendorf","year":"2015","unstructured":"Nahrendorf M, Frantz S, Swirski FK, Mulder WJM, Randolph G, Ertl G, et al. Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol. 2015;65:1583\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"440_CR6","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.2353\/ajpath.2006.051021","volume":"169","author":"JH Chidlow","year":"2006","unstructured":"Chidlow JH, Langston W, Greer JJM, Ostanin D, Abdelbaqi M, Houghton J, et al. Differential angiogenic regulation of experimental colitis. Am J Pathol. 2006;169:2014\u201330.","journal-title":"Am J Pathol"},{"key":"440_CR7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ddstr.2008.11.003","volume":"5","author":"XF Yang","year":"2008","unstructured":"Yang XF, Yin Y, Wang H. Vascular inflammation and atherogenesis are activated via receptors for PAMPs and suppressed by regulatory T cells. Drug Discov Today Ther Strateg. 2008;5:125\u201342.","journal-title":"Drug Discov Today Ther Strateg"},{"key":"440_CR8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/039463200902200208","volume":"22","author":"Y Yin","year":"2009","unstructured":"Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, et al. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol. 2009;22:311\u201322.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"440_CR9","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.atherosclerosis.2009.12.017","volume":"210","author":"J Shen","year":"2010","unstructured":"Shen J, Yin Y, Mai J, Xiong X, Pansuria M, Liu J, et al. Caspase-1 recognizes extended cleavage sites in its natural substrates. Atherosclerosis. 2010;210:422\u20139.","journal-title":"Atherosclerosis"},{"key":"440_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13045-016-0351-5","volume":"9","author":"L Wang","year":"2016","unstructured":"Wang L, Fu H, Nanayakkara G, Li Y, Shao Y, Johnson C, et al. Novel extracellular and nuclear caspase-1 and inflammasomes propagate inflammation and regulate gene expression: a comprehensive database mining study. J Hematol & Oncol. 2016;9:122.","journal-title":"J Hematol & Oncol"},{"key":"440_CR11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-014-0080-6","volume":"7","author":"Y Shao","year":"2014","unstructured":"Shao Y, Cheng Z, Li X, Chernaya V, Wang H, Yang XF. Immunosuppressive\/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction--a novel mechanism for maintaining vascular function. J Hematol Oncol. 2014;7:80.","journal-title":"J Hematol Oncol"},{"key":"440_CR12","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/ATVBAHA.115.305282","volume":"35","author":"Y Yin","year":"2015","unstructured":"Yin Y, Li X, Sha X, Xi H, Li YF, Shao Y, et al. Early hyperlipidemia promotes endothelial activation via a caspase-1-sirtuin 1 pathway. Arter Thromb Vasc Biol. 2015;35:804\u201316.","journal-title":"Arter Thromb Vasc Biol"},{"key":"440_CR13","doi-asserted-by":"crossref","first-page":"17485","DOI":"10.1074\/jbc.M115.641191","volume":"290","author":"J Lopez-Pastrana","year":"2015","unstructured":"Lopez-Pastrana J, Ferrer LM, Li Y-F, Xiong X, Xi H, Cueto R, et al. Inhibition of caspase-1 activation in endothelial cells improves angiogenesis: a novel therapeutic potential for ischemia. J Biol Chem. 2015;290:17485\u201394.","journal-title":"J Biol Chem"},{"key":"440_CR14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12265-016-9683-3","volume":"9","author":"LM Ferrer","year":"2016","unstructured":"Ferrer LM, Monroy AM, Lopez-Pastrana J, Nanayakkara G, Cueto R, Li Y-F, et al. Caspase-1 plays a critical role in accelerating chronic kidney disease-promoted neointimal hyperplasia in the carotid artery. J Cardiovasc Transl Res. 2016;9:135\u201344.","journal-title":"J Cardiovasc Transl Res"},{"key":"440_CR15","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1161\/CIRCRESAHA.116.308501","volume":"118","author":"H Xi","year":"2016","unstructured":"Xi H, Zhang Y, Xu Y, Yang WY, Jiang X, Sha X, et al. Caspase-1 inflammasome activation mediates homocysteine-induced pyrop-apoptosis in endothelial cells novelty and significance. Circ Res. 2016;118:1525\u201339.","journal-title":"Circ Res"},{"key":"440_CR16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2741\/4383","volume":"21","author":"Y-F Li","year":"2016","unstructured":"Li Y-F, Huang X, Li X, Gong R, Yin Y, Nelson J, et al. Caspase-1 mediates hyperlipidemia-weakened progenitor cell vessel repair. Front Biosci (Landmark Ed). 2016;21:178\u201391.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"440_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-015-0130-8","volume":"8","author":"YF Li","year":"2015","unstructured":"Li YF, Ren LN, Guo G, Cannella LA, Chernaya V, Samuel S, et al. Endothelial progenitor cells in ischemic stroke: an exploration from hypothesis to therapy. J Hematol Oncol. 2015;8:33.","journal-title":"J Hematol Oncol"},{"key":"440_CR18","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.2741\/3217","volume":"13","author":"Z Xiong","year":"2008","unstructured":"Xiong Z, Song J, Yan Y, Huang Y, Cowan A, Wang H, et al. Higher expression of Bax in regulatory T cells increases vascular inflammation. Front Biosci. 2008;13:7143\u201355.","journal-title":"Front Biosci"},{"key":"440_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2008.07.041","volume":"203","author":"Z Xiong","year":"2009","unstructured":"Xiong Z, Yan Y, Song J, Fang P, Yin Y, Yang Y, et al. Expression of TCTP antisense in CD25(high) regulatory T cells aggravates cuff-injured vascular inflammation. Atherosclerosis. 2009;203:401\u20138.","journal-title":"Atherosclerosis"},{"key":"440_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41038-015-0001-0","volume":"3","author":"WY Yang","year":"2015","unstructured":"Yang WY, Shao Y, Lopez-Pastrana J, Mai J, Wang H, Yang X. Pathological conditions re-shape physiological Tregs into pathological Tregs. Burn Trauma. 2015;3:1.","journal-title":"Burn Trauma"},{"key":"440_CR21","doi-asserted-by":"crossref","first-page":"e33628","DOI":"10.1371\/journal.pone.0033628","volume":"7","author":"X Li","year":"2012","unstructured":"Li X, Mai J, Virtue A, Yin Y, Gong R, Sha X, et al. IL-35 is a novel responsive anti-inflammatory cytokine\u2014a new system of categorizing anti-inflammatory cytokines. PLoS One. 2012;7:e33628.","journal-title":"PLoS One"},{"key":"440_CR22","doi-asserted-by":"crossref","first-page":"19307","DOI":"10.1074\/jbc.M115.663286","volume":"290","author":"X Sha","year":"2015","unstructured":"Sha X, Meng S, Li X, Xi H, Maddaloni M, Pascual DW, et al. Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 pathway. J Biol Chem. 2015;290:19307\u201318.","journal-title":"J Biol Chem"},{"key":"440_CR23","doi-asserted-by":"crossref","first-page":"a009092","DOI":"10.1101\/cshperspect.a009092","volume":"5","author":"M Shibuya","year":"2013","unstructured":"Shibuya M. VEGFR and type-V RTK activation and signaling. Cold Spring Harb Perspect Biol. 2013;5:a009092.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"440_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tcm.2012.04.005","volume":"21","author":"ZZ Chong","year":"2011","unstructured":"Chong ZZ, Shang YC, Maiese K. Cardiovascular disease and mTOR signaling. Trends Cardiovasc Med. 2011;21:151\u20135.","journal-title":"Trends Cardiovasc Med"},{"key":"440_CR25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrrheum.2015.164","volume":"12","author":"SW Tas","year":"2016","unstructured":"Tas SW, Maracle CX, Balogh E, Szekanecz Z. Targeting of proangiogenic signalling pathways in chronic inflammation. Nat Rev Rheumatol. 2016;12:111\u201322.","journal-title":"Nat Rev Rheumatol"},{"key":"440_CR26","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/hum.2013.2516","volume":"24","author":"SM Kaminsky","year":"2013","unstructured":"Kaminsky SM, Rosengart TK, Rosenberg J, Chiuchiolo MJ, Van de Graaf B, Sondhi D, et al. Gene therapy to stimulate angiogenesis to treat diffuse coronary artery disease. Hum Gene Ther. 2013;24:948\u201363.","journal-title":"Hum Gene Ther"},{"key":"440_CR27","unstructured":"National Center of Biotechnology Information Unigene Library. http:\/\/www.ncbi.nlm.nih.gov\/unigene . Accessed March 2016."},{"key":"440_CR28","unstructured":"NCBI GEO2R. http:\/\/www.ncbi.nlm.nih.gov\/geo\/geo2r\/ . Accessed May 2016."},{"key":"440_CR29","unstructured":"Ingenuity Pathway Analysis. http:\/\/www.ingenuity.com\/ . Accessed October 2016."},{"key":"440_CR30","unstructured":"Genecards. http:\/\/www.genecards.org\/ . Accessed December 2016."},{"key":"440_CR31","doi-asserted-by":"crossref","unstructured":"Binder JX, Pletscher-Frankild S, Tsafou K, Stolte C, O\u2019Donoghue SI, Schneider R, et al. COMPARTMENTS: unification and visualization of protein subcellular localization evidence. Database. 2014;2014:bau012-bau012.","DOI":"10.1093\/database\/bau012"},{"key":"440_CR32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","volume":"86","author":"D Hanahan","year":"1996","unstructured":"Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell. 1996;86:353\u201364.","journal-title":"Cell"},{"key":"440_CR33","doi-asserted-by":"crossref","unstructured":"Jeltsch M, Lepp\u00e4nen VM, Saharinen P, Alitalo K. Receptor tyrosine kinase-mediated angiogenesis. Cold Spring Harb Perspect Biol. 2013;5.","DOI":"10.1101\/cshperspect.a009183"},{"key":"440_CR34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrrheum.2015.157","volume":"12","author":"Z Szekanecz","year":"2016","unstructured":"Szekanecz Z, Koch AE. Successes and failures of chemokine-pathway targeting in rheumatoid arthritis. Nat Rev Rheumatol. 2016;12:5\u201313.","journal-title":"Nat Rev Rheumatol"},{"key":"440_CR35","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nri2634","volume":"9","author":"R Medzhitov","year":"2009","unstructured":"Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat Rev Immunol. 2009;9:692\u2013703.","journal-title":"Nat Rev Immunol"},{"key":"440_CR36","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nm.3653","volume":"20","author":"SJ Forbes","year":"2014","unstructured":"Forbes SJ, Rosenthal N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat Med. 2014;20:857\u201369.","journal-title":"Nat Med"},{"key":"440_CR37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663\u201376.","journal-title":"Cell"},{"key":"440_CR38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2012.03.008","volume":"320","author":"F Shojaei","year":"2012","unstructured":"Shojaei F. Anti-angiogenesis therapy in cancer: current challenges and future perspectives. Cancer Lett. 2012;320:130\u20137.","journal-title":"Cancer Lett"},{"key":"440_CR39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.cell.2016.07.032","volume":"166","author":"D Clever","year":"2016","unstructured":"Clever D, Roychoudhuri R, Constantinides MG, Askenase MH, Sukumar M, Klebanoff CA, et al. Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche. Cell. 2016;166:1117\u201331. e14.","journal-title":"Cell"},{"key":"440_CR40","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.critrevonc.2013.01.002","volume":"87","author":"D Mukherji","year":"2013","unstructured":"Mukherji D, Temraz S, Wehbe D, Shamseddine A. Angiogenesis and anti-angiogenic therapy in prostate cancer. Crit Rev Oncol Hematol. 2013;87:122\u201331.","journal-title":"Crit Rev Oncol Hematol"},{"key":"440_CR41","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/ATVBAHA.113.302991","volume":"34","author":"S Alias","year":"2014","unstructured":"Alias S, Redwan B, Panzenb\u00f6ck A, Winter MP, Schubert U, Voswinckel R, et al. Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2014;34:810\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"440_CR42","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/ATVBAHA.113.302998","volume":"34","author":"CE Evans","year":"2014","unstructured":"Evans CE, Grover SP, Humphries J, Saha P, Patel AP, Patel AS, et al. Antiangiogenic therapy inhibits venous thrombus resolution. Arterioscler Thromb Vasc Biol. 2014;34:565\u201370.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"440_CR43","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1161\/ATVBAHA.110.215038","volume":"30","author":"CE Evans","year":"2010","unstructured":"Evans CE, Humphries J, Mattock K, Waltham M, Wadoodi A, Saha P, et al. Hypoxia and upregulation of hypoxia-inducible factor 1\u03b1 stimulate venous thrombus recanalization. Arterioscler Thromb Vasc Biol. 2010;30:2443\u201351.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"440_CR44","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/eurheartj\/eht543","volume":"36","author":"R Klingenberg","year":"2015","unstructured":"Klingenberg R, Brokopp CE, Griv\u00e8s A, Courtier A, Jaguszewski M, Pasqual N, et al. Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes. Eur Heart J. 2015;36:1041\u20138.","journal-title":"Eur Heart J"},{"key":"440_CR45","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/eurheartj\/ehq084","volume":"31","author":"CA Wyss","year":"2010","unstructured":"Wyss CA, Neidhart M, Altwegg L, Spanaus KS, Yonekawa K, Wischnewsky MB, et al. Cellular actors, Toll-like receptors, and local cytokine profile in acute coronary syndromes. Eur Heart J. 2010;31:1457\u201369.","journal-title":"Eur Heart J"},{"key":"440_CR46","doi-asserted-by":"crossref","unstructured":"Jakob P, Kacprowski T, Briand-Schumacher S, Heg D, Klingenberg R, St\u00e4hli BE, et al. Profiling and validation of circulating microRNAs for cardiovascular events in patients presenting with ST-segment elevation myocardial infarction. Eur Heart J. 2016:ehw563.","DOI":"10.1093\/eurheartj\/ehw563"},{"key":"440_CR47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev-cellbio-092910-154002","volume":"27","author":"AS Chung","year":"2011","unstructured":"Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annu Rev Cell Dev Biol. 2011;27:563\u201384.","journal-title":"Annu Rev Cell Dev Biol"},{"key":"440_CR48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-4781(95)00116-X","volume":"1264","author":"RS Bandyopadhyay","year":"1995","unstructured":"Bandyopadhyay RS, Phelan M, Faller DV. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim Biophys Acta. 1995;1264:72\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"440_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/15216540252774766","volume":"52","author":"C Michiels","year":"2001","unstructured":"Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life. 2001;52:49\u201353.","journal-title":"IUBMB Life"},{"key":"440_CR50","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","volume":"8","author":"JML Ebos","year":"2011","unstructured":"Ebos JML, Kerbel RS. Antiangiogenic therapy: impact on invasion, disease progression, and metastasis. Nat Rev Clin Oncol. 2011;8:210\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"440_CR51","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1582-4934.2011.01258.x","volume":"15","author":"A Carreau","year":"2011","unstructured":"Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C. Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med. 2011;15:1239\u201353.","journal-title":"J Cell Mol Med"},{"key":"440_CR52","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","volume":"22","author":"E Berra","year":"2003","unstructured":"Berra E, Benizri E, Ginouv\u00e8s A, Volmat V, Roux D, Pouyss\u00e9gur J. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1\u03b1 in normoxia. EMBO J. 2003;22:4082\u201390.","journal-title":"EMBO J"},{"key":"440_CR53","doi-asserted-by":"crossref","unstructured":"Tian H, Mcknight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. 1997:72\u201382.","DOI":"10.1101\/gad.11.1.72"},{"key":"440_CR54","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","volume":"8","author":"C Fischer","year":"2008","unstructured":"Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer. 2008;8:942\u201356.","journal-title":"Nat Rev Cancer"},{"key":"440_CR55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-319-38810-6_5","volume":"923","author":"N Esen","year":"2016","unstructured":"Esen N, Vejalla A, Sharma R, Treuttner JS, Dore-Duffy P. Hypoxia-induced Let-7d has a role in pericyte differentiation. Adv Exp Med Biol. 2016;923:37\u201342.","journal-title":"Adv Exp Med Biol"},{"key":"440_CR56","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1038\/ncomms5511","volume":"5","author":"JM Siegle","year":"2014","unstructured":"Siegle JM, Basin A, Sastre-Perona A, Yonekubo Y, Brown J, Sennett R, et al. SOX2 is a cancer-specific regulator of tumour initiating potential in cutaneous squamous cell carcinoma. Nat Commun. 2014;5:4511.","journal-title":"Nat Commun"},{"key":"440_CR57","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1038\/onc.2014.257","volume":"34","author":"D Zhao","year":"2015","unstructured":"Zhao D, Pan C, Sun J, Gilbert C, Drews-Elger K, Azzam DJ, et al. VEGF drives cancer-initiating stem cells through VEGFR-2\/Stat3 signaling to upregulate Myc and Sox2. Oncogene. 2015;34:3107\u201319.","journal-title":"Oncogene"},{"key":"440_CR58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/IJWH.S78101","volume":"8","author":"R Wenham","year":"2016","unstructured":"Wenham R, McClung E. Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives. Int J Womens Health. 2016;8:59.","journal-title":"Int J Womens Health"},{"key":"440_CR59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2147\/OTT.S49429","volume":"7","author":"T Schefter","year":"2014","unstructured":"Schefter T, Jackson M, Rusthoven C, Fisher C. Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence. Oncol Targets Ther. 2014;7:751.","journal-title":"Oncol Targets Ther"},{"key":"440_CR60","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.2009.27.2757","volume":"28","author":"TK Choueiri","year":"2010","unstructured":"Choueiri TK, Schutz FAB, Je Y, Rosenberg JE, Bellmunt J. Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials. J Clin Oncol. 2010;28:2280\u20135.","journal-title":"J Clin Oncol"},{"key":"440_CR61","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3109\/02841860903524396","volume":"49","author":"V Ranpura","year":"2010","unstructured":"Ranpura V, Hapani S, Chuang J, Wu S. Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials. Acta Oncol (Madr). 2010;49:287\u201397.","journal-title":"Acta Oncol (Madr)"},{"key":"440_CR62","doi-asserted-by":"crossref","first-page":"17485","DOI":"10.1074\/jbc.M115.641191","volume":"290","author":"J Lopez-Pastrana","year":"2015","unstructured":"Lopez-Pastrana J, Ferrer LM, Li YF, Xiong X, Xi H, Cueto R, et al. Inhibition of caspase-1 activation in endothelial cells improves angiogenesis: a novel therapeutic potential for ischemia. J Biol Chem. 2015;290:17485\u201394.","journal-title":"J Biol Chem"},{"key":"440_CR63","doi-asserted-by":"crossref","unstructured":"Tabas I. 2016 Russell Ross Memorial Lecture in Vascular Biology. Arterioscler Thromb Vasc Biol. 2016;:ATVBAHA.116.308036.","DOI":"10.1161\/ATVBAHA.116.308036"},{"key":"440_CR64","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fonc.2014.00131","volume":"4","author":"A Bruno","year":"2014","unstructured":"Bruno A, Pagani A, Pulze L, Albini A, Dallaglio K, Noonan DM, et al. Orchestration of angiogenesis by immune cells. Front Oncol. 2014;4:131.","journal-title":"Front Oncol"},{"key":"440_CR65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/cr.2013.165","volume":"24","author":"L Fu","year":"2014","unstructured":"Fu L, Zhu X, Yi F, Liu G-H, Izpisua Belmonte JC. Regenerative medicine: transdifferentiation in vivo. Cell Res. 2014;24:141\u20132.","journal-title":"Cell Res"},{"key":"440_CR66","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","volume":"118","author":"MR Bennett","year":"2016","unstructured":"Bennett MR, Sinha S, Owens GK. Vascular smooth muscle cells in atherosclerosis. Circ Res. 2016;118:692\u2013702.","journal-title":"Circ Res"}],"container-title":["Journal of Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-017-0440-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T23:29:36Z","timestamp":1568935776000},"score":1,"resource":{"primary":{"URL":"http:\/\/jhoonline.biomedcentral.com\/articles\/10.1186\/s13045-017-0440-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,23]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["440"],"URL":"https:\/\/doi.org\/10.1186\/s13045-017-0440-0","relation":{},"ISSN":["1756-8722"],"issn-type":[{"type":"electronic","value":"1756-8722"}],"subject":[],"published":{"date-parts":[[2017,3,23]]},"article-number":"74"}}